Pet insurance provider Trupanion (NASDAQ: TRUP) will be reporting results this Wednesday after the bell. Here’s what to expect.
Trupanion beat analysts’ revenue expectations last quarter, reporting revenues of $384 million, up 12.3% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS and book value per share estimates.
Is Trupanion a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Trupanion’s revenue to grow 10.2% year on year, slowing from the 12.3% increase it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Trupanion has a history of exceeding Wall Street’s expectations.
Looking at Trupanion’s peers in the property & casualty insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. First American Financial delivered year-on-year revenue growth of 15%, beating analysts’ expectations by 3.4%, and CNA Financial reported revenues up 1.9%, topping estimates by 1.2%. First American Financial traded down 2.2% following the results.
Read our full analysis of First American Financial’s results here and CNA Financial’s results here.
Investors in the property & casualty insurance segment have had steady hands going into earnings, with share prices up 1.3% on average over the last month. Trupanion is down 7.3% during the same time and is heading into earnings with an average analyst price target of $37.25 (compared to the current share price of $24.92).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
